The Challenge
A leading BAP Pharma client required urgent local sourcing in China for a decentralised clinical study in immunology. The immediate need was to secure supply of Skyrizi® 360 mg and 600 mg within an accelerated one-month timeline, without disrupting patient treatment or wider study continuity.
Operating in a complex local market under significant time pressure, the client needed more than product access alone. Any delay could have interrupted treatment schedules, created operational risk, and placed unnecessary pressure on study timelines and patient experience.
The BAP Pharma Approach
Drawing on its established global sourcing network and trusted local partnerships, BAP Pharma moved quickly to secure supply through a reputable partner in China. The team managed product availability, pricing and procurement at pace, while also providing additional support through the management and English translation of prescribing information documentation.
BAP Pharma also ensured compliant onboarding of product into both the sponsor’s and BAP Pharma’s ERP systems, enabling a smooth and efficient path from sourcing to delivery. The result was a coordinated, locally enabled solution delivered within the required timeframe.
The Outcome
The client received the required supply on time and without disruption, allowing patient treatment to continue as planned and study continuity to be maintained.
By combining speed, local market access and disciplined execution, BAP Pharma mitigated operational risk and delivered confidence in a situation where there was little tolerance for delay. The engagement demonstrated the value of a sourcing partner able to remove uncertainty and maintain momentum, even in challenging regional markets.
